Cargando…
EMBR-17. DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE FOR-WNT STUDY
BACKGROUND: Medulloblastoma is a heterogenous disease comprising four molecular subgroups (WNT, SHH, Group 3, and Group 4) with varying outcomes. Excellent long-term survival (>90%) has prompted de-intensification of therapy in WNT-subgroup medulloblastoma globally. FOR-WNT is one such prospectiv...
Autores principales: | Gupta, Tejpal, Pervez, Shizan, Dasgupta, Archya, Chatterjee, Abhishek, Krishnatry, Rahul, GodaSastri, Jayant, Prasad, Maya, Chinnaswamy, Girish, Epari, Sridhar, Sahay, Ayushi, Shirsat, Neelam, Shetty, Prakash, Moiyadi, Aliasgar, Shaikh, Farnaz, Bano, Nazia, Jalali, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168092/ http://dx.doi.org/10.1093/neuonc/noab090.035 |
Ejemplares similares
-
EMBR-14. INFLUENCE OF MRI FEATURES ON THE SURVIVAL AND IMPACT ON INDIVIDUAL MOLECULAR SUBGROUPS: RESULT FROM 171 PATIENTS WITH MEDULLOBLASTOMA
por: Dasgupta, Archya, et al.
Publicado: (2021) -
MEDB-27. Clinico-Radiological Outcomes in WNT-pathway Medulloblastoma: Retrospective Single Institutional Audit
por: Mani, Shakthivel, et al.
Publicado: (2022) -
WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?
por: Mani, Shakthivel, et al.
Publicado: (2023) -
EMBR-28. CNS DISTRIBUTIONAL KINETICS OF PANOBINOSTAT IN THE MOUSE
por: Zhang, Wenqiu, et al.
Publicado: (2021) -
EMBR-18. LASER INTERSTITIAL THERMAL THERAPY FOR RECURRENT MEDULLOBLASTOMA
por: Xu, Jordan, et al.
Publicado: (2021)